Searched for
TSUTOMU UNE
Daiichi Sankyo vs Singh Brothers: How a diary note made the differenceThe revelation of the "journal" is part of a controversial book Bottle of Lies released recently.- Sebi may reopen insider trading case against Sun PharmaAlleged irregularities in raising funds through FCCBs are likely to be probed by the watchdog, said sources.
- Ranbaxy Laboratories' TL Easwar of API quits post ‘introspection’A few weeks after the meeting, its head of API manufacturing, TL Easwar, left the company, two people with direct knowledge of the matter t...
- ITC expresses interest to set a Food Park in LudhianaITC today evinced interest in signing an MoU with the Punjab government for setting up a Food Park in Ludhiana district besides building fo...
- Daiichi Sankyo has not been able to manage Ranbaxy: Malvinder Singh, Former chairmanSingh described the testimony of whistleblower that formed the basis of investigations as 'sensational', and said he rejected these charges.
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- India-Japan trade to touch $25 billion by 2014: StudyThe trade between India and Japan is likely to touch $25 billion by 2014 on the back of a trade deal that the two countries signed in 2011.
- No plans to delist: Ranbaxy chairmanRanbaxy Laboratories today said the company has no plans to delist from Indian bourses and it will remain a listed company.
- Ranbaxy, Daiichi start joint community initiative in IndiaRanbaxy Laboratories and its parent Daiichi Sankyo today announced a joint community initiative in India with the flag-off of two mobile ru...
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.
- Ranbaxy gains over 5% in trade; drug release on trackShares of Ranbaxy climbed over 5 per cent in trade on Thursday on reports that the company will release a generic version Lipitor in the US...
- Daiichi's own man to head Ranbaxy qualityJapan's Daiichi Sankyo has named an executive with more than 25 years of experience to oversee the quality and manufacturing standards in R...
- Ranbaxy shareholders approve BSR & Co as auditorRanbaxy Laboratories on Monday said its shareholders have approved the appointment of BSR & Co as the auditor of the company till the next ...
- Daiichi to leverage Ranbaxy abroadJapan’s Daiichi Sankyo, which controls Ranbaxy Laboratories, will use the Indian company as a launch pad to sell its patented drugs in Euro...
- Daiichi Sankyo to launch Ranbaxy's drugs in Japan soonDaiichi Sankyo is going to launch some of Ranbaxy's generic medicine in the Japanese market soon.
- Ranbaxy misses May deadline to supply raw materials to AstrazenecaSupplies to Astrazeneca which could have potentially brought revenues of $40 million this year (May-December 2009) has been delayed by 2-3 ...
- Ranbaxy shareholders gain Rs 1,900 cr in a single dayInvestors in Ranbaxy Laboratories got richer by over Rs 1,900 crore in a single day as the scrip surged by a little over 20 per cent on the...
- Stocks to watch: ONGC, RIL, Ranbaxy, Reliance Infra, Mphasis, Era InfraThe Indian rupee fell on Monday against the the US dollar, snapping its six-session upward journey, on expectations of fresh capital outflo...
- Ranbaxy Laboratories rejigs board, Malvinder is chairmanRanbaxy Laboratories and its new owner Japan’s Daiichi Sankyo on Friday reconstituted a new 10-member board.
- Daiichi looking to merge its Indian subsidiary with RanbaxyDaiichi Sankyo said that it is looking to merge its Indian subsidiary with Ranbaxy Laboratories, in which it has acquired a majority stake.
Load More
